Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort

BACKGROUND: Autophagy is an important oncotarget that can be modulated during anti-cancer therapy. Enhancing autophagy using chemotherapy and rapamycin (Rapa) treatment and then inhibiting it using hydroxychloroquine (HCQ) could synergistically improve therapy outcome in cancer patients. It is still...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Kwan-Hwa, Ko, Hui-Ling, Yang, Kai-Lin, Lee, Cheng-Yen, Chi, Mau-Shin, Kao, Shang-Jyh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599303/
https://www.ncbi.nlm.nih.gov/pubmed/25944689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599303/
https://www.ncbi.nlm.nih.gov/pubmed/25944689

Ejemplares similares